In the COVID-19 Era, Are In-Person Conferences Worth the Risks?
In-person medical conferences are back in full swing this year, and members of the oncology community are weighing the risks…
Update: The Number of People Not Up to Date on Vaccination in Counties with Elevated COVID-19 Community Levels is Growing
With the Omicron wave of COVID-19 sweeping the country, we previously calculated the number of people who were not up…
KFF COVID-19 Vaccine Monitor: July 2022
More than a year after COVID-19 vaccines were made widely available to adults in the U.S., the FDA recently granted…
COVID-19 Vaccination Rates Among Children Under 5 Have Peaked and Are Decreasing Just Weeks Into Their Eligibility
Children between the ages of 6 months and 5 years of age finally became eligible for COVID-19 vaccination in the…
Paxlovid Use for COVID-19 May Be Feasible in Advanced CKD
Patients with advanced chronic kidney disease (CKD) have increased risks for hospitalization and death after COVID-19 infection. Yet PaxlovidTM (nirmatrelvir…
Lack of Mask Mandates Leaves Cancer Patients Feeling Unprotected
A lack of mask mandates at cancer centers and elsewhere has left cancer patients feeling unsafe and abandoned by society.…
Pharmacists Allowed to Prescribe Paxlovid for COVID-19 Treatment
State-licensed pharmacists can now prescribe Paxlovid (nirmatrelvir tablets co-packaged with ritonavir tablets) with certain limitations to eligible patients, according to…